Warfarin–Herbal Interaction in a Patient with Atrial Fibrillation
A 68-year-old man with atrial fibrillation is stabilized on warfarin (INR 2.5–3.0) for stroke prevention. He recently started taking a herbal supplement containing Ginkgo biloba (120 mg twice daily) and garlic oil capsules (1000 mg daily) to 'improve circulation' and 'prevent colds.' He presents to the pharmacy with a 3-day history of gum bleeding when brushing teeth and one episode of epistaxis. His last INR was 2.8 two weeks ago. He denies changes in diet or other medications. The pharmacist suspects an interaction.
1. Explain the pharmacological basis for the potential interaction between warfarin and the herbal products (Ginkgo biloba and garlic), and assess the likelihood that the bleeding symptoms are due to this interaction.
Read the worked answer
Pharmacological basis:
- Warfarin is a vitamin K antagonist that inhibits clotting factors II, VII, IX, X. It has a narrow therapeutic index; bleeding risk increases with supratherapeutic INR or additive antihemostatic effects.
- Ginkgo biloba contains ginkgolides, particularly ginkgolide B, which is a potent platelet-activating factor (PAF) antagonist. This inhibits platelet aggregation and can prolong bleeding time. Additionally, some evidence suggests ginkgo may induce or inhibit CYP enzymes, but the primary concern is antiplatelet activity.
- Garlic (Allium sativum) has antiplatelet effects via inhibition of platelet aggregation (possibly by interfering with thromboxane synthesis and calcium mobilization). It may also have fibrinolytic activity.
- Both agents can additively increase bleeding risk when combined with warfarin, even if INR remains in range, because they affect primary hemostasis (platelet function) rather than the extrinsic pathway measured by INR.
Likelihood assessment:
The patient's symptoms (gum bleeding, epistaxis) are consistent with increased bleeding tendency. The temporal relationship (started herbs recently) and the known mechanisms make the interaction probable. However, other causes (e.g., overanticoagulation, underlying disease) should be ruled out. An INR should be checked immediately; if INR is within range, the bleeding may be due to platelet dysfunction from the herbs. The pharmacist should advise discontinuation of the herbs and monitor.
2. Outline the pharmacist's course of action, including counseling points and monitoring plan, to manage this potential interaction safely.
Read the worked answer
Immediate actions:
- Assess bleeding severity: The patient has mild bleeding (gum, epistaxis) but no major bleeding (e.g., melena, hematuria). Refer to a physician if bleeding is persistent or severe.
- Check INR today (point-of-care if available) to rule out overanticoagulation.
- Advise discontinuation of ginkgo and garlic supplements. Explain the reason (increased bleeding risk).
- Counsel on warfarin adherence and avoid other OTC/herbal products that interact (e.g., NSAIDs, St. John's wort).
- Document the interaction in the patient's pharmacy record and communicate with the prescriber.
Monitoring plan:
- Recheck INR in 3–5 days after discontinuation to ensure stability.
- Monitor for signs of bleeding (bruising, dark stools, blood in urine).
- Educate on bleeding precautions (soft toothbrush, electric razor).
- If INR is supratherapeutic (>4.0), consider vitamin K administration per protocol.
Counseling points:
- Herbal products are not risk-free; always consult pharmacist before starting.
- Maintain consistent vitamin K intake (green leafy vegetables).
- Report any unusual bleeding immediately.
- Avoid alcohol binges and unnecessary OTC medications.
Follow-up: Schedule a follow-up call in 1 week to assess bleeding and reinforce education.